These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 32517459)
1. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer]. Lin Y; Li H; Huang M; Yin Z; Wu J Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier Integrity in Lung Cancer Patients with Leptomeningeal Metastasis]. Lin Y; Yu T; Li H; Yin Z; Guo A Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432 [TBL] [Abstract][Full Text] [Related]
3. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer. Wang P; Piao Y; Zhang X; Li W; Hao X Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis. Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807 [TBL] [Abstract][Full Text] [Related]
5. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer. Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828 [TBL] [Abstract][Full Text] [Related]
6. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers. Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289 [TBL] [Abstract][Full Text] [Related]
7. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China. Ma L; Xie XW; Wang HY; Ma LY; Wen ZG Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610 [TBL] [Abstract][Full Text] [Related]
8. [Investigation of Methods and Influencing Factors to Increase the Positive Rate of Cytological Pathology of Cerebrospinal Fluid from Lung Cancer Leptomeningeal Metastases]. Gao N; Teng C; Fan C; Xin T Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):789-796. PubMed ID: 36419392 [TBL] [Abstract][Full Text] [Related]
9. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer]. Ren Z; Ding HM; Qian X; Pan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239 [No Abstract] [Full Text] [Related]
10. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis. Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of Clinicopathological Feature and Prognosis for Leptomeningeal Metastasis in Non-small Cell Lung Cancer]. Zhu M; Ren Y; Liu Y; Ban C; Gu H; Wang Z; Zhang Y Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):533-8. PubMed ID: 27561804 [TBL] [Abstract][Full Text] [Related]
12. The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer. Wu H; Wang Q; Liu Q; Zhang Q; Huang Q; Yu Z Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162867 [TBL] [Abstract][Full Text] [Related]
13. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases. van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288 [TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Jiang ZF; Wang M; Xu JL Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745 [TBL] [Abstract][Full Text] [Related]
15. Prediction of lung cancer based on serum biomarkers by gene expression programming methods. Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226 [TBL] [Abstract][Full Text] [Related]
16. Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis. Yan W; Liu Y; Li J; Han A; Kong L; Yu J; Zhu H Radiat Oncol; 2019 Sep; 14(1):168. PubMed ID: 31521171 [TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era. Riess JW; Nagpal S; Iv M; Zeineh M; Gubens MA; Ramchandran K; Neal JW; Wakelee HA Clin Lung Cancer; 2014 May; 15(3):202-6. PubMed ID: 24524822 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. Miao Q; Zheng X; Li L; Zheng X; Zhang L; Jiang K; Wu S; Wang H; Wu B; Xu Y; Zhong Q; Zou Z; Zhang Q; Yang S; Li Y; Lin G J Neurooncol; 2023 Dec; 165(3):517-525. PubMed ID: 38104049 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer. Sun M; Song J; Zhou Z; Zhu R; Jin H; Ji Y; Lu Q; Ju H Dis Markers; 2016; 2016():3823121. PubMed ID: 26880855 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers. Nakagawa K; Takano K; Nishino K; Ohe S; Nakayama T; Arita H J Neurooncol; 2024 May; 167(3):397-406. PubMed ID: 38430420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]